Medical device startup Cardiac Success closes $5.2 million Series A
Proceeds will be used for pre-clinical testing and the completion of a First-in-Human trial of the company’s innovative “V-sling” heart failure therapy
CTech | 20:35 04.07.2021
Cardiac Success, an Israel-based medical device company developing a transcatheter ventricular repair device for heart failure patients, has announced the closing of a $5.2 million Series A financing round. The round was led by 415 CAPITAL, a specialist VC firm that primarily backs innovative medical technology companies in the cardio-and neurovascular space. The round was joined by an unnamed global strategic leader in structural heart interventions and a group of Israeli angel investors. Headquartered in Yokneam, Cardiac Success was founded in 2017 in the Alon Medtech Ventures’ incubator by serial entrepreneur Dr. Shimon Eckhouse and Dr. David Neustadter (Chief Technology Officer). The company’s management team includes Boaz Manash (CEO), an experienced R&D leader previously responsible for the Sapien M3 mitral valve program at Edwards Lifesciences and Prof. Rafael Beyar (Chief Medical Officer), an internationally-recognized cardiologist and former director of Rambam Medical Center.